These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7819825)

  • 21. Economic evaluation of cell salvage in pediatric surgery.
    Samnaliev M; Tran CM; Sloan SR; Gasior I; Lightdale JR; Brustowicz RM
    Paediatr Anaesth; 2013 Nov; 23(11):1027-34. PubMed ID: 23952976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity-based costs of blood transfusions in surgical patients at four hospitals.
    Shander A; Hofmann A; Ozawa S; Theusinger OM; Gombotz H; Spahn DR
    Transfusion; 2010 Apr; 50(4):753-65. PubMed ID: 20003061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative autologous blood donation: clinical, economic, and ethical issues.
    Domen RE
    Cleve Clin J Med; 1996 Sep; 63(5):295-300. PubMed ID: 8870340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients.
    Shermock KM; Horn E; Lipsett PA; Pronovost PJ; Dorman T
    Crit Care Med; 2005 Mar; 33(3):497-503. PubMed ID: 15753738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost and utilization of blood transfusion associated with spinal surgeries in the United States.
    Blanchette CM; Wang PF; Joshi AV; Asmussen M; Saunders W; Kruse P
    Eur Spine J; 2007 Mar; 16(3):353-63. PubMed ID: 16463198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Economic Impact of Using a Restrictive Transfusion Trigger Among Patients Undergoing Major Abdominal Surgery.
    Ejaz A; Frank SM; Spolverato G; Kim Y; Pawlik TM
    JAMA Surg; 2015 Jul; 150(7):625-30. PubMed ID: 25946411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.
    Blumberg N; Kirkley SA; Heal JM
    Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transfusion of recuperated blood in total knee arthroplasty].
    Pitsaer E
    Rev Chir Orthop Reparatrice Appar Mot; 2002 Dec; 88(8):777-89. PubMed ID: 12503019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.
    Tretiak R; Laupacis A; Rivière M; McKerracher K; Souêtre E
    CMAJ; 1996 May; 154(10):1501-8. PubMed ID: 8625000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reduction in the use of donated blood in surgical medicine].
    Gombotz H; Kulier A
    Anaesthesist; 1995 Mar; 44(3):191-218. PubMed ID: 7762780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
    Green WS; Toy P; Bozic KJ
    J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous blood transfusion.
    Slater NG
    Malays J Pathol; 1991 Dec; 13(2):67-73. PubMed ID: 1823094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations.
    Muñoz M; García-Erce JA; Villar I; Thomas D
    Vox Sang; 2009 Jan; 96(1):1-13. PubMed ID: 19121192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rational use of blood cell products in orthopedics and traumatology].
    Knöller SM; Brieschal T
    Z Orthop Ihre Grenzgeb; 2004; 142(1):109-14. PubMed ID: 14968394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion practices for elective orthopedic surgery.
    Feagan BG; Wong CJ; Johnston WC; Arellano R; Colterjohn N; Karkouti K; Turner K
    CMAJ; 2002 Feb; 166(3):310-4. PubMed ID: 11868638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood utilization: fostering an effective hospital transfusion culture.
    Sherman CH; Macivor DC
    J Clin Anesth; 2012 Mar; 24(2):155-63. PubMed ID: 22414711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model.
    Custer B; Agapova M; Martinez RH
    Transfusion; 2010 Nov; 50(11):2461-73. PubMed ID: 20497512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient blood management: a 68-year-old woman contemplating autologous blood donation before elective surgery.
    Uhl L
    JAMA; 2011 Nov; 306(17):1902-10. PubMed ID: 21990097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A survey of autologous blood collection and transfusion in Japan in 1997.
    Ohto H; Fuji T; Wakimoto N; Anan M; Maeda H
    Transfus Sci; 2000; 22(1-2):13-8. PubMed ID: 10771374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative hemodilution is more cost-effective than preoperative autologous donation for patients undergoing procedures associated with a low risk for transfusion.
    Rosenblatt MA; Cantos EM; Mohandas K
    J Clin Anesth; 1997 Feb; 9(1):26-9. PubMed ID: 9051542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.